Risk for Autoimmune Inflammatory Rheumatic Disease Increased After SARS-CoV-2
By Elana Gotkine HealthDay Reporter
TUESDAY, March 5, 2024 -- Patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have an increased risk for incident autoimmune inflammatory rheumatic disease (AIRD) compared with matched patients with influenza infection or uninfected controls, according to a study published online March 5 in the Annals of Internal Medicine.
Min Seo Kim, M.D., from the Broad Institute of MIT and Harvard in Boston, and colleagues examined the effect of COVID-19 on the long-term risk for incident AIRD during various follow-up periods in a binational, longitudinal study. Data were included for 10,027,506 Korean and 12,218,680 Japanese patients aged 20 years or older, including those with COVID-19 matched to patients with influenza and uninfected controls. The primary outcome was AIRD onset one, six, and 12 months after infection or matched index date.
Among the Korean patients, 3.9 and 0.98 percent had a history of COVID-19 or influenza, respectively, between 2020 and 2021. The researchers found that after propensity score matching, patients with COVID-19 had an increased risk for incident AIRD beyond the first 30 days after infection compared with uninfected controls and influenza-infected controls (adjusted hazard ratios, 1.25 and 1.30, respectively). With more severe acute COVID-19, the risk for incident AIRD was higher. In the Japanese cohort, similar patterns were observed.
"This population-based cohort study shows that the increased risk for incident AIRD extends up to 12 months after SARS-CoV-2 infection," the authors write. "Care strategies for patients who survive COVID-19 should pay close attention to manifestations of AIRD, particularly after severe COVID-19."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Further Support and Information on COVID-19
Read this next
Following Drop After COVID-19 Onset, Inappropriate Antibiotic Prescribing Is Up
WEDNESDAY, May 1, 2024 -- There was an initial decrease in inappropriate antibiotic prescriptions following onset of COVID-19, followed by an increase, according to a study...
Long-Term Smell, but Not Taste, Deficits Seen After COVID-19
WEDNESDAY, May 1, 2024 -- Olfactory dysfunction, especially for smell, is more common in individuals with prior COVID-19 versus individuals with no history of infection, with...
SARS-CoV-2 Vaccine Does Not Increase New-Onset Seizure Risk
TUESDAY, April 30, 2024 -- There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.